The store will not work correctly when cookies are disabled.
2,6-difluoro-4-(9-isopentyl-9H-purin-2-ylamino)phenol
ID: ALA4858257
PubChem CID: 164609895
Max Phase: Preclinical
Molecular Formula: C16H17F2N5O
Molecular Weight: 333.34
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)CCn1cnc2cnc(Nc3cc(F)c(O)c(F)c3)nc21
Standard InChI: InChI=1S/C16H17F2N5O/c1-9(2)3-4-23-8-20-13-7-19-16(22-15(13)23)21-10-5-11(17)14(24)12(18)6-10/h5-9,24H,3-4H2,1-2H3,(H,19,21,22)
Standard InChI Key: OYTSXCFOGSTFSE-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
21.0276 -4.0416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0265 -4.8690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7413 -5.2819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4577 -4.8685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4548 -4.0380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7395 -3.6288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7370 -2.8038 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
20.3131 -3.6292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.3116 -5.2809 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.1728 -5.2798 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8867 -4.8662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5984 -5.2780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.5907 -3.6280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8804 -4.0433 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3077 -4.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3146 -4.8612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1127 -5.1314 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.5857 -4.4365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0932 -3.7706 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.3749 -5.9137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8285 -6.5319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0907 -7.3141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5443 -7.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8992 -7.4781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
1 8 1 0
2 9 1 0
4 10 1 0
10 11 1 0
11 12 2 0
12 16 1 0
15 13 1 0
13 14 2 0
14 11 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 2 0
19 15 1 0
17 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
22 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 333.34 | Molecular Weight (Monoisotopic): 333.1401 | AlogP: 3.60 | #Rotatable Bonds: 5 |
Polar Surface Area: 75.86 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.28 | CX Basic pKa: 1.54 | CX LogP: 3.64 | CX LogD: 3.59 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.70 | Np Likeness Score: -1.17 |
References
1. Casalvieri KA, Matheson CJ, Warfield BM, Backos DS, Reigan P.. (2021) N-Substituted pyrrolopyrimidines and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors., 41 [PMID:34034149] [10.1016/j.bmc.2021.116220] |